Abiopharma

🔍 Intrator Michael N (Director)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 134,067 shares of Class A Common Stock at $88.3052 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,553,062.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 62,293 shares of Class A Common Stock at $89.1719 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,490,769.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,640 shares of Class A Common Stock at $89.9306 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,487,129.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Acquired 107,692 shares of Class A Common Stock (Direct)
  Date: 2026-08-25 | Code: C | equity_swap_involved: 0 | shares_owned_after: 107,692.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Sold 72,186 shares of Class A Common Stock at $88.3052 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,506.00 | transaction_form_type: 4 | Footnotes: F1, F7, F6
• Sold 33,546 shares of Class A Common Stock at $89.1718 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,960.00 | transaction_form_type: 4 | Footnotes: F1, F3, F6
• Sold 1,960 shares of Class A Common Stock at $89.9306 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F6
• Sold 107,692 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: C | equity_swap_involved: 0 | shares_owned_after: 22,587,740.00 | transaction_form_type: 4 | Footnotes: F5, F5, F5, F5, F6
• Holds 21,867,489 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: H | shares_owned_after: 21,867,489.00 | Footnotes: F5, F5, F5
• Holds 365,200 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: H | shares_owned_after: 365,200.00 | Footnotes: F5, F5, F5, F8
• Holds 4,576,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: H | shares_owned_after: 4,576,000.00 | Footnotes: F5, F5, F5, F9
• Holds 2,290,320 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: H | shares_owned_after: 2,290,320.00 | Footnotes: F5, F5, F5, F10
• Holds 136,947 shares of Class B Common Stock (Derivative)
  Date: 2026-08-25 | Code: H | shares_owned_after: 136,947.00 | Footnotes: F5, F5, F5, F11

Footnotes:

• F1: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.78 to $88.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.78 to $89.77, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.78 to $90.11, inclusive.
• F5: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F6: The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.78 to $88.77, inclusive.
• F8: The reported securities are directly held by the reporting person's spouse.
• F9: The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F10: The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F11: The reported securities are directly held by PMI 2024 F&F GRAT Remainder Trust, an irrevocable trust with a third-party trustee, of which certain of the reporting person's immediate family members are beneficiaries. The reporting person has the power to remove and replace the trustee. The reporting person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest, if any.